Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- 1506 1
- 2019-nCoV Vaccine mRNA-1273 3
- 2019-nCoV Vaccine MRNA-1273 1
- Adolescent 3
- Adult 7
- Aged 5
- Analysis 1
- Anti-Retroviral Agents 1
- Antibodies, Viral 1
- Antitubercular Agents 1
- Aolescent 1
- BNT162 Vaccine 4
- Case-Control Studies 1
- Chemoprophylaxis 1
- Cluster Analysis 1
- Cohort Studies 1
- Community-Acquired Infections 1
- CoronaVirus Infections 4
- COVID-19 8
- COVID-19 Vaccines 6
- COVID-19/Prevention & Control 1
- Dispatch 1
- Epidemics 1
- Exanthema 1
- Female 7
- Full Report 1
- Genotype 1
- HIV Infections 2
- HIV infections 1
- Hospitalization 7
- Hospital Mortality 2
- Hospitals, Veterans 2
- Humans 10
- Immunization, Secondary 1
- Immunization Schedule 1
- Immunocompetence 1
- Immunocompromised Host 1
- Incidence 1
- Isoniazid 1
- Male 7
- Middle Aged 6
- Molecular Epidemiology 1
- mRNA Vaccines 1
- Mycobacterium Tuberculosis 1
- Niacin 1
- Oxygen 1
- Patient Acuity 1
- Pellagra 1
- Prevalence 1
- Prevention strategies 1
- Public Health 1
- Research Article 1
- Respiration, Artificial 2
- Respiratory Syncytial Virus, Human 1
- Respiratory Syncytial Virus Infections/prevention & control 1
- Respiratory Syncytial Virus Vaccines/adverse Effects 1
- Risk factors 1
- RNA, Messenger 2
- SARS-CoV-2 6
- Time Factors 1
- Tuberculosis 4
- United States 2
- Vaccination 2
- Vaccine Efficacy 5
- Vaccines 1
- Vaccines, Combined 2
- Vaccines, Synthetic 2
- Veterans 2
- Veterans Health Services 1
- Vitamin B Complex 1
- World Health Organization 1
- Young Adult 3
Personal Author
Corporate Author
- Baylor College of Medicine. Department of Medicine. 1
- Baylor Scott & White Health. 1
- Baystate Medical Center, Springfield, Massachusetts 1
- CDC COVID-19 Emergency Response Team. 1
- CDC COVID-19 Response Team. 1
- COVID-19 Surveillance Group 2
- David Geffen School of Medicine. Department of Medicine. 1
- Emory University School of Medicine. Department of Medicine. 1
- for the Kopanyo Study Group 1
- General Dynamics Information Technology. 1
- Greater Los Angeles Veterans Affairs Healthcare System (U.S.). 1
- Hennepin County Medical Center. 1
- Icahn School of Medicine at Mount Sinai. Department of Medicine. 1
- Intermountain Medical Center. 1
- Investigating Respiratory Viruses in the Acutely Ill (IVY) Network 1
- IVY Network 4
- IVY Network. 1
- James J. Peters Veterans Affairs Medical Center (Bronx, NY) 1
- Johns Hopkins Hospital. 1
- Karna, LLC. 1
- Michael E. DeBakey Veterans Affairs Medical Center (Houston, Tex.) 1
- Montefiore Medical Center and Albert Einstein College of Medicine. 1
- National Center for Immunization and Respiratory Diseases (U.S.). Coronavirus and Other Respiratory Viruses Division. 1
- Rollins School of Public Health. Department of Global Health. 1
- Stanford University School of Medicine.Department of Medicine. 1
- SUPERNOVA COVID-19 Surveillance Group 2
- Surveillance Platform for Enteric and Respiratory Infectious Organisms at the VA (SUPERNOVA) 2
- Texas A&M University College of Medicine. 1
- United States Department of Veterans Affairs. 12Public Health Surveillance and Research. 1
- University of Colorado School of Medicine, Aurora, Colorado 1
- University of Iowa. 1
- University of Michigan School of Public Health. 1
- University of Utah. 1
- University of Washington School of Medicine. 1
- Vanderbilt University Medical Center, Nashville, Tennessee. 1
- VA Palo Alto Health Care System (U.S.) 1
- Veterans Affairs Medical Center (Atlanta, Ga.) 1
- Wake Forest University Baptist Medical Center. 1
Place as Subject
- Africa South of the Sahara 1
- Botswana 1
- California 1
- Colorado 1
- Florida 1
- Georgia 1
- India 1
- Iowa 1
- Maryland 1
- Massachusetts 1
- Michigan 1
- Minnesota 1
- Missouri 1
- New York 1
- North Carolina 1
- Ohio 1
- Oregon 1
- Tennessee 1
- Texas 1
- U.S. 2
- United States 4
- Utah 1
- Washington 1
Resource Type General
Resource Type Specific
Keywords
- COVID-19 1
- death 1
- hospitalization 1
- SARS-CoV-2 1
- severe disease 1
Select all docs (Max 200)
1 -
14 of 14 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- 1506 (1)
- 2019-nCoV Vaccine mRNA-1273 (3)
- 2019-nCoV Vaccine MRNA-1273 (1)
- Adolescent (3)
- Adult (7)
- Aged (5)
- Analysis (1)
- Anti-Retroviral Agents (1)
- Antibodies, Viral (1)
- Antitubercular Agents (1)
- Aolescent (1)
- BNT162 Vaccine (4)
- Case-Control Studies (1)
- Chemoprophylaxis (1)
- Cluster Analysis (1)
- Cohort Studies (1)
- Community-Acquired Infections (1)
- CoronaVirus Infections (4)
- COVID-19 (8)
- COVID-19 Vaccines (6)
- COVID-19/Prevention & Control (1)
- Dispatch (1)
- Epidemics (1)
- Exanthema (1)
- Female (7)
- Full Report (1)
- Genotype (1)
- HIV Infections (2)
- HIV infections (1)
- Hospitalization (7)
- Hospital Mortality (2)
- Hospitals, Veterans (2)
- Humans (10)
- Immunization, Secondary (1)
- Immunization Schedule (1)
- Immunocompetence (1)
- Immunocompromised Host (1)
- Incidence (1)
- Isoniazid (1)
- Male (7)
- Middle Aged (6)
- Molecular Epidemiology (1)
- mRNA Vaccines (1)
- Mycobacterium Tuberculosis (1)
- Niacin (1)
- Oxygen (1)
- Patient Acuity (1)
- Pellagra (1)
- Prevalence (1)
- Prevention strategies (1)
- Public Health (1)
- Research Article (1)
- Respiration, Artificial (2)
- Respiratory Syncytial Virus, Human (1)
- Respiratory Syncytial Virus Infections/prevention & control (1)
- Respiratory Syncytial Virus Vaccines/adverse Effects (1)
- Risk factors (1)
- RNA, Messenger (2)
- SARS-CoV-2 (6)
- Time Factors (1)
- Tuberculosis (4)
- United States (2)
- Vaccination (2)
- Vaccine Efficacy (5)
- Vaccines (1)
- Vaccines, Combined (2)
- Vaccines, Synthetic (2)
- Veterans (2)
- Veterans Health Services (1)
- Vitamin B Complex (1)
- World Health Organization (1)
- Young Adult (3)
- Baylor College of Medicine. Department of Medicine. (1)
- Baylor Scott & White Health. (1)
- Baystate Medical Center, Springfield, Massachusetts (1)
- CDC COVID-19 Emergency Response Team. (1)
- CDC COVID-19 Response Team. (1)
- COVID-19 Surveillance Group (2)
- David Geffen School of Medicine. Department of Medicine. (1)
- Emory University School of Medicine. Department of Medicine. (1)
- for the Kopanyo Study Group (1)
- General Dynamics Information Technology. (1)
- Greater Los Angeles Veterans Affairs Healthcare System (U.S.). (1)
- Hennepin County Medical Center. (1)
- Icahn School of Medicine at Mount Sinai. Department of Medicine. (1)
- Intermountain Medical Center. (1)
- Investigating Respiratory Viruses in the Acutely Ill (IVY) Network (1)
- IVY Network (4)
- IVY Network. (1)
- James J. Peters Veterans Affairs Medical Center (Bronx, NY) (1)
- Johns Hopkins Hospital. (1)
- Karna, LLC. (1)
- Michael E. DeBakey Veterans Affairs Medical Center (Houston, Tex.) (1)
- Montefiore Medical Center and Albert Einstein College of Medicine. (1)
- National Center for Immunization and Respiratory Diseases (U.S.). Coronavirus and Other Respiratory Viruses Division. (1)
- Rollins School of Public Health. Department of Global Health. (1)
- Stanford University School of Medicine.Department of Medicine. (1)
- SUPERNOVA COVID-19 Surveillance Group (2)
- Surveillance Platform for Enteric and Respiratory Infectious Organisms at the VA (SUPERNOVA) (2)
- Texas A&M University College of Medicine. (1)
- United States Department of Veterans Affairs. 12Public Health Surveillance and Research. (1)
- University of Colorado School of Medicine, Aurora, Colorado (1)
- University of Iowa. (1)
- University of Michigan School of Public Health. (1)
- University of Utah. (1)
- University of Washington School of Medicine. (1)
- Vanderbilt University Medical Center, Nashville, Tennessee. (1)
- VA Palo Alto Health Care System (U.S.) (1)
- Veterans Affairs Medical Center (Atlanta, Ga.) (1)
- Wake Forest University Baptist Medical Center. (1)
- Africa South of the Sahara (1)
- Botswana (1)
- California (1)
- Colorado (1)
- Florida (1)
- Georgia (1)
- India (1)
- Iowa (1)
- Maryland (1)
- Massachusetts (1)
- Michigan (1)
- Minnesota (1)
- Missouri (1)
- New York (1)
- North Carolina (1)
- Ohio (1)
- Oregon (1)
- Tennessee (1)
- Texas (1)
- U.S. (2)
- United States (4)
- Utah (1)
- Washington (1)
- :Surie, Diya ;Borgdorff, Martien W.Sep 26 2018 | BMC Infect Dis. 18.:BackgroundHIV is a major driver of the tuberculosis epidemic in sub-Saharan Africa. The population-level impact of antiretroviral therapy (ART) scale-...
- :Moonan, Patrick K ;Nair, Sreenivas AOct 08 2018 | BMJ Glob Health. 2018; 3(5).:The End TB Strategy envisions a world free of tuberculosis-zero deaths, disease and suffering due to tuberculosis by 2035. This requires reducing the ...
- :Surie, Diya ;Fane, OthusitseMar 15 2017 | Emerg Infect Dis. 23(3):487-490.:During 2012-2015, 10 of 24 patients infected with matching genotypes of Mycobacterium tuberculosis received care at the same hospital in Gaborone, Bot...
- :Surie, DiyaJune 26, 2024 | ACIP meeting Respiratory Syncytial Virus Vaccines – Adult:07-RSV-Adult-Surie-508.pdf
- :Nabity, Scott A ;Mponda, Kelvin5 2022 | Lancet Glob Health. 10(5):e705-e714:BackgroundPellagra is caused by niacin (vitamin B3) deficiency and patients with pellagra present with a characteristic rash. Isoniazid disrupts intra...
- :Tenforde, Mark W. ;Self, Wesley H.3 25 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):COVID-19 mRNA vaccines (BNT162b2 [Pfizer-BioNTech] and mRNA-1273 [Moderna]) are effective at preventing COVID-19-associated hospitalization (1-3). How...
- :Bajema, Kristina L. ;Dahl, Rebecca M.9 17 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) have been shown to be highly protective against COVID-19-associated hospitalizations (1-3). Data ...
- :Bajema, Kristina L. ;Dahl, Rebecca M.12 10 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):The mRNA COVID-19 vaccines (Moderna and Pfizer-BioNTech) provide strong protection against severe COVID-19, including hospitalization, for at least se...
- :Tenforde, Mark W. ;Self, Wesley H.March 18, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):What is already known about this topic? COVID-19 mRNA vaccines provide protection against COVID-19 hospitalization among adults. However, how well mRN...
- :Bajema, Kristina L. ;Dahl, Rebecca M.September 10, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):What is already known about this topic? mRNA COVID-19 vaccines are effective in preventing severe COVID-19 outcomes, including hospitalization.What is...
- :Tenforde, Mark W. ;Patel, Manish M.1 28 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):COVID-19 mRNA vaccines (BNT162b2 [Pfizer-BioNTech] and mRNA-1273 [Moderna]) provide protection against infection with SARS-CoV-2, the virus that cause...
- :Surie, Diya ;DeCuir, Jennifer12 30 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Monovalent COVID-19 mRNA vaccines, designed against the ancestral strain of SARS-CoV-2, successfully reduced COVID-19-related morbidity and mortality ...
- :Surie, Diya ;Bonnell, Levi10 21 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):The SARS-CoV-2 Omicron variant (B.1.1.529 or BA.1) became predominant in the United States by late December 2021 (1). BA.1 has since been replaced by ...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.